Reversible hyponatremia and venlafaxine [1]

Psychosomatics

Volumn 46, Issue 5, 2005, Pages 495-496

  Bourgeois, James A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM; VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL EXAMINATION; COGNITIVE DEFECT; DELIRIUM; DEPRESSION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LABORATORY TEST; LETHARGY; LETTER; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SODIUM BLOOD LEVEL; AGED; BLOOD; CHEMICALLY INDUCED DISORDER; PSYCHOLOGICAL ASPECT;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYCLOHEXANOLS; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYPONATREMIA; SODIUM;

EID: 32944481486     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.46.5.495     Document Type: Letter

References (7)

1. Buff DD, Markowitz S: Hyponatremia in the psychiatric population: a review of diagnostic and management strategies. Psychiatr Ann 2003; 33:318-325
2. Bugunovic OJ, Sotelo J, Madhusoodanan S: Hyponatremia secondary to antidepressants. Psychiatr Ann 2003; 33:333-339
3. Kirby D, Harrigan S, Ames D: Hyponatremia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit. Int J Geriatr Psychiatry 2002; 17:231-237
4. Boyd IW: Comment: hyponatremia with venlafaxine. Ann Pharmacother 1998; 32:981
5. Masood GR, Karki SD, Patterson WR: Hyponatremia with venlafaxine. Ann Pharmacother 1998; 32:49-50
6. Roxanas MG: Mirtazepine-induced hyponatraemia. Med J Aust 2003; 179:453-454
7. Morton WA, Sonne SC, Verga MA: Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother 1995; 29:387-395